Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and rifampin

quinoxalines has been researched along with rifampin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sadrieh, N; Snyderwine, EG1
Bugaeva, OK; Makarovskaya, LN; Pavlovich, NV; Ryzhkova, VV; Zurabyan, VA1
López De Ceráin, A; Monge, A; Montoya, ME; Ortega, MA; Sainz, Y1
López de Ceráin, A; Martínez-Crespo, FJ; Monge, A; Montoya, ME; Ortega, MA; Sainz, Y1
Aldana, I; Ancizu, S; Benítez, D; Burguete, A; Cerecetto, H; González, M; Marín, A; Monge, A; Moreno, E; Pérez-Silanes, S; Solano, B; Torres, E; Villar, R1

Other Studies

5 other study(ies) available for quinoxalines and rifampin

ArticleYear
Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Carcinogenesis, 1995, Volume: 16, Issue:7

    Topics: Animals; Biotransformation; Cytochrome P-450 Enzyme System; Enzyme Induction; Erythrocebus patas; Female; Humans; Hydroxylation; Immunoblotting; Isoenzymes; Macaca fascicularis; Male; Microsomes, Liver; Mutagenicity Tests; Mutagens; Polychlorinated Dibenzodioxins; Quinolines; Quinoxalines; Rats; Rifampin; Species Specificity; Substrate Specificity

1995
[In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1997, Volume: 42, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Complement Activation; Doxycycline; Erythromycin; Furazolidone; Guinea Pigs; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillins; Plague; Polymyxin B; Quinoxalines; Rifampin; Yersinia pestis

1997
Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
    Die Pharmazie, 1999, Volume: 54, Issue:1

    Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinoxalines; Rifampin; Spectrophotometry, Infrared; Structure-Activity Relationship

1999
New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
    Arzneimittel-Forschung, 1999, Volume: 49, Issue:1

    Topics: Antibiotics, Antitubercular; Antitubercular Agents; Cyclic N-Oxides; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinoxalines; Rifampin

1999
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
    Molecules (Basel, Switzerland), 2009, Jun-22, Volume: 14, Issue:6

    Topics: Animals; Antitubercular Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium tuberculosis; Quinoxalines; Rifampin; Trypanosoma

2009